Livmarli

Generic name: maralixibat chloride

Used for: Itching from Alagille syndrome · Itching from PFIC (an inherited liver disease) · 1 more

How do you pay?

How to pay the least

Ask for the cash price

Livmarli

We didn’t find one.

  1. Ask your pharmacy for Livmarli’s cash price, and one or two other pharmacies too.
  2. Livmarli’s savings card works only with insurance from a job or one you bought.

Compare every option

Question
Brand nameLivmarli
Authorized genericmaralixibat chloride
Regular genericmaralixibat chloride
What you’d pay
Cash priceAsk the pharmacy
Not soldThere isn’t one
Not soldNone found
Same as Livmarli?
The original
–
–

Brand nameThe maker’s card

Mirum Access Plus Savings Program

Savings card from Mirum Pharmaceuticals

No insuranceNeeds insuranceNo cash price listed.
Insurance · as little as $0 a fill

Sign up on mirumaccessplus.com 

Or call 1-855-676-4968.

In the maker’s words

“Eligible patients with commercial or private insurance may pay as little as $0 out of pocket per fill for LIVMARLI.”

From the maker’s offer on mirumaccessplus.com, checked November 2, 2026. Co-pay cards can’t be used with Medicare (including Medicare Advantage), Medicaid, TRICARE or VA.

Maker’s card or discount card?

A discount card like GoodRx lowers the pharmacy’s cash price, but for a brand-name drug that price often stays high. Compare it with the maker’s card above. You can usually use one or the other on a fill, not both.

Authorized genericNot sold

There isn’t one. An authorized generic is Livmarli itself, from the same company, sold without the brand name, and usually for less. For now Livmarli is the only choice; its maker’s savings card can lower what you pay.

See the brand name →

Regular genericNot sold

We didn’t find one. Generics usually come once the brand’s patents and exclusivity end. Until then, the maker’s savings card is the way to pay less.

See the brand name →

What it’s used for

What the FDA label says

LIVMARLI is an ileal bile acid transporter (IBAT) inhibitor indicated for:

  • the treatment of cholestatic pruritus in patients 3 months of age and older with Alagille syndrome (ALGS).
  • the treatment of cholestatic pruritus in patients 12 months of age and older with progressive familial intrahepatic cholestasis (PFIC).
    • o Limitations of Use: LIVMARLI is not recommended in a subgroup of PFIC type 2 patients with specific ABCB11 variants resulting in non-functional or complete absence of bile salt export pump (BSEP) protein.

Source: the FDA label for Livmarli (Mirum Pharmaceuticals Inc.), April 10, 2025. Full label on DailyMed 

Good to know

Prices checked November 2, 2026. Prices change: confirm with the pharmacy before you fill. drugalt.com/drug/livmarli/